Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Multi-asset pipeline with significant targeted data readouts and milestones -- Two lead ophthalmic gene therapy programs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback